Phase 2 Gestational Trophoblastic Neoplasia Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital70 enrolled1 locationNCT05139095
Recruiting
Phase 2
Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7
Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital17 enrolled1 locationNCT06020755
Recruiting
Phase 2
A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia
Gestational Trophoblastic NeoplasiaGestational Trophoblastic DiseaseGestational Trophoblastic Tumor, Recurrent
Imperial College London20 enrolled1 locationNCT05635344
Recruiting
Phase 1Phase 2
Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
Gestational Trophoblastic Neoplasias (GTN)
Hospices Civils de Lyon26 enrolled9 locationsNCT04396223
Recruiting
Phase 2
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University20 enrolled1 locationNCT04812002